Successful first-time use of antibodies to interferon-γ alone and combined with antibodies to tumor necrosis factor-α to treat rheumatic diseases (rheumatoid arthritis, systemic lupus erythematosus, psoriatic arthritis, Behcet's syndrome)

International Journal of Immunotherapy

Volumn 14, Issue 1, 1998, Pages 23-32

  Skurkovich, S V ^a,d   Loukina, G V ^b   Sigidin, Y A ^b   Skurkovich, B ^a,c  

^a Advanced Biotherapy   (United States)

^b V A NASONOVA RESEARCH INSTITUTE OF RHEUMATOLOGY   (Russian Federation)

^c BROWN UNIVERSITY   (United States)

^d NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERFERON ANTIBODY; POLYCLONAL ANTIBODY; TUMOR NECROSIS FACTOR ALPHA ANTIBODY;

ADULT; ARTICLE; BEHCET DISEASE; CLINICAL ARTICLE; HUMAN; INTRAMUSCULAR DRUG ADMINISTRATION; PSORIATIC ARTHRITIS; RHEUMATOID ARTHRITIS; SYSTEMIC LUPUS ERYTHEMATOSUS;

EID: 0031904939     PISSN: 02559625     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Skurkovich S V., Klinova K G., Eremkina E.I., Levina N.V Immunosuppressive effect of an anti-interferon serum Nature, 217, 551, 1974.
2. Skurkovich S.V., Eremkina E.I. Probable role of Interferon in allergy Ann Allergy, 35, 356, 1975
3. Hooks J.J., Moutsopoulos H.M , Gels S.A., et al. Immune Interferon in the circulation of patients with autoimmune disease. N. Eng. J. Med 301, 5, 1979.
4. Osial T.A., Pazin G.J., Ho M., et al. Serum Interferon (IF) levels in connective tissue disease. Clin Res., 29, 160A, 1981
5. Skurkovich S., Skurkovich B., Bellanti J.A. A unifying model of the immunoregulatory role of the interferon system: can interferon produce disease in humans? Clin. Immunol. Immunopathol , 43, 362, 1987.
6. Foulis A K , Farquharson M.A., Meager A. Immunoreactive alpha-interferon in insulin-secreting beta cells in type 1 diabetes mellitus. Lancet, 2, 1423, 1987.
7. Livden J.K , Nilsen R., Bjerke J R., Matre R. In situ localization of interferons in psonatic lesions. Arch. Dermatol. Res., 281, 392, 1989
8. Shiozawa S., Kuroki Y, Kim M., Hirohata S., Ogino T. Interferon-alpha in lupus psychosis. Arthr. Rheum , 35, 417, 1992.
9. Skurkovich S.V., Skorikova A.S., Dubrovina N.A., et al. Lymphocytes' cytotoxicity towards cells of human lymphoblastoid fines in patients with rheumatoid arthritis and systemic lupus erythematosus. Ann. Allergy, 39, 344, 1977.
10. Hereman S, Billiau A., Colombatti A., et al. Interferon treatment of NZB mice: accelerated progression of autoimmune disease Infect Immun., 21, 925, 1978.
11. Carpenter D.F., Steinberg A.D., Schur RH , Talal N. The pathogenesis of autoimmunity in New Zealand mice II. Acceleration of glomerulonephritis by polyinosinic polycytidylic acid. Lab Invest., 23, 628, 1970.
12. Engelman E D, Sonnenfeld G., Dauphinee M., et al. Treatment of NZB/NZW F2 hybrid mice with mycobacterium bovis strain BCG or type II Interferon preparations accelerates autoimmune disease. Arthr. Rheum., 24, 1396, 1981.
13. Bevan P.C. Interferon-induced parotitis and epididymitis. Lancet, 2, 561, 1985
14. Machold K.P , Smolen J.S. Interferon-gamma induced exacerbation of systemic lupus erythematosus. J. Rheum., 17, 831, 1990.
15. Conlon K.C., Urba W.J., Smith J W, et al. Exacerbation of symptoms of autoimmune disease in patients receiving alpha-interferon therapy. Cancer, 65, 2237, 1990
16. Chazerain P, Meyer O., Kahn M-F Rheumatoid arthritis-like disease after alpha-interferon therapy. Ann. Intern Med , 116, 427, 1992
17. Jacob C.O., van der Meide P.H., McDevitt H.O. In vivo treatment of (NZB x WZW) F1 lupus-like nephritis with monoclonal antibody to gamma Interferon. J Exp. Med., 166, 798, 1987.
18. Ewel C., Sobel D.O., Bellanti J.A. Poly I:C accelerates development of diabetes mellitus in diabetes-prone BB rat. Diabetes, 419, 1016, 1992
19. Nicoletti F, Meroni P L , Landolf S., et al. Prevention of diabetes in BB/Wor rats treated with monoclonal antibodies to gamma Interferon. Lancet, 336, 319, 1990.
20. Lau A S , Livesey J.F Endotoxin induction of tumor necrosis factor is enhanced by acid-labile interferon-α in acquired immunodeficiency syndrome. AIDS Res Human Retrovir., 7, 545, 1991
21. Skurkovich S V., Skurkovich B. Development of autoimmune disease is connected with the initial disturbance of IFN synthesis in the cells. J IFN Res., 9 S2, Oct., 1989.
22. Skurkovich S., Skurkovich B. A new approach to the treatment of autoimmune diseases and AIDS In: "New Americans Collected Scientific Reports". Rich R. (Ed.). Bnai Zion Soviet American Scientists Division, New York, 1991, pp 163-167.
23. Skurkovich S V , Skurkovich B. Aberrant IFN may help HIV survive and replicate. Its removal in AIDS patients may halt this process and help restore the immune system. J IFN Res., 12 S1, Abstr. 1.6, 1992.
24. Skurkovich S, Skurkovich B., Bellanti J.A Can disturbances of IFN synthesis trigger AD? Sem. in Clin . Immunol., 4, 5, 1992.
25. Skurkovich S., Skurkovich B., Bellanti J.A A disturbance of interferon synthesis with the hyperproduction of unusual kinds of interferon can trigger autoimmune disease and play a pathogenetic role in AIDS. the removal of these interferons can be therapeutic Med Hypoth., 41, 177, 1993.
26. Skurkovich S . Skurkovich B., Bellanti J.A. A disturbance of interferon synthesis with the hyperproduction of unusual kinds of interferon can trigger autoimmune disease and play a pathogenetic role in AIDS: the removal of these interferons can be therapeutic Med Hypoth., 42, 27, 1994
27. Elliott M J Maini R N , Feldmann M., et al Treatment of rheumatoid arthritis with chimaeric monoclonal antibodies to tumor necrosis factor-α Arthritis Rheum , 36, 1681, 1993.
28. Skurkovich S.V , Klinova E.G , Aleksandrovskaya L M., et al. Interferon stimulation of transplantation immunity and cellular reactions of humoral immunity in mice. Proc XIIl ISBT Cong . Washington, DC. Oct 18, 1972, 39
29. Skurkovich S V , Klinova E.G , Aleksandrovskaya L M., et al. Stimulation of transplantation immunity and plasma cell reaction by interferon in mice. 13 25, 317, 1973.
30. Bellanti J A., Skurkovich S.V., Peters S.M., Arias G. Treatment of AIDS patients with antialpha IFN: an alternative approach. Second Ann. Conf. Clin. Immunol, Clin. Immunol, Soc., (Oct. 30 - Nov. 1, Washington) 1987.
31. Gringeri A., Santagostino E., Cucini M., et al. Absence of clinical, biological, and immunological signs of progression in HIV-1 infected patients receiving active anti-IFN-α immunization. Thirty month follow-up report. J. Acquir. Immune Defic. Syndr Hum Retrovirol., 13, 55, 1996.
32. Demina T.L., Buglak A.B., Bolieva I.A., et al. Anti-interferon-γ and anti-tumor necrosis factor-α antibodies reduce the rate of progression in secondary progressive multiple sclerosis (MS). 5th Ann. Conf. Int. Cytokine Soc., (Nov. 9-13, Lake Tahoe) 1997.